Severe acute respiratory syndrome coronavirus-2 antibody prevalence in people with and without HIV in rural Western Kenya, January to March 2020

Trevor A Crowell; Ibrahim I Daud; Jonah Maswai; John Owuoth; Valentine Sing'oei; Michelle Imbach; Nicole Dear; Fred Sawe; Leigh Anne Eller; Christina S Polyak; Julie A Ake; AFRICOS Study Group

doi:10.1097/QAD.0000000000003054

Severe acute respiratory syndrome coronavirus-2 antibody prevalence in people with and without HIV in rural Western Kenya, January to March 2020

AIDS. 2021 Nov 15;35(14):2401-2404. doi: 10.1097/QAD.0000000000003054.

Authors

Trevor A Crowell^{1

2}, Ibrahim I Daud³, Jonah Maswai^{1

3}, John Owuoth^{4

5}, Valentine Sing'oei^{4

5}, Michelle Imbach^{1

2}, Nicole Dear^{1

2}, Fred Sawe^{3

4}, Leigh Anne Eller^{1

2}, Christina S Polyak^{1

2}, Julie A Ake¹; AFRICOS Study Group

Affiliations

¹ U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring.
² Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
³ HJF Medical Research International, Kericho.
⁴ US Army Medical Research Directorate - Africa, Kisumu, and.
⁵ HJF Medical Research International, Kisumu, Kenya.

Abstract

Among 582 participants in Western Kenya who were retrospectively tested from January through March 2020, 19 (3.3%) had detectable SARS-CoV-2 antibodies. The prevalence of detectable SARS-CoV-2 antibodies was similar between participants with and without HIV (3.1% vs. 4%, P = 0.68). One participant reported a cough in the preceding week but others denied symptoms. These may represent cross-reactivity or asymptomatic infections that predated the first reported COVID-19 cases in Kenya.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Viral / blood*
COVID-19 / diagnosis*
HIV Infections* / epidemiology
Humans
Kenya / epidemiology
Prevalence
Retrospective Studies
SARS-CoV-2 / immunology

Substances

Antibodies, Viral